/Companies

Adipopharma

Strasbourg, FR · 2 known investors

Find your way into Adipopharma

Sign up to see every warm intro you have to Adipopharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Adipopharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AdipoPharma is a biotech company developing therapies based on the endocrine biology of adipose tissue and targeted rare genetic disorders. Founded in 2022 (formerly ALMS Therapeutics), its work relates to metabolic diseases such as diabetes and obesity.

Founders & leadership

VMVincent Marion
Vincent MarionFounder
CPCatherine Perot
Catherine PerotChief Financial Officer
MJMichael J. Fare
Michael J. FareChief Operating OfficerMichael J. Fare is Chief Operating Officer of AdipoPharma, a biotech company developing therapies for metabolic and rare genetic disorders. He has held roles in drug discovery and development, project management, and business development, including positions at Wyeth-Ayerst where he worked on pharmaceutical marketing and international business development.
TGTarekegn G. Hiwot
Tarekegn G. HiwotChief Medical Officer

Investors · 2

Frequently asked questions

What does Adipopharma do?
AdipoPharma is a biotech company developing therapies based on the endocrine biology of adipose tissue and targeted rare genetic disorders. Founded in 2022 (formerly ALMS Therapeutics), its work relates to metabolic diseases such as diabetes and obesity.
Who founded Adipopharma?
Adipopharma was founded by Vincent Marion.
Who are Adipopharma's investors?
Adipopharma's investors include Good Growth Capital, Newton Biocapital.
Where is Adipopharma headquartered?
Adipopharma is headquartered in Strasbourg, FR.